Comac Medical is delighted to announce our participation in Outsourcing in Clinical Trials (OCT) DACH 2025, taking place on November 12–13, 2025, at the Kameha Grand Zurich, Autograph Collection, in Zurich, Switzerland.

This flagship event, organized by Arena International, brings together senior clinical operations professionals from across the DACH region to discuss innovative approaches, best practices, and strategies for optimizing clinical trials.

Representing Comac Medical will be Diana Gheorghi, Business Development Director, who will be available to meet with sponsors, CROs, and industry partners to explore how Comac Medical’s global expertise and integrated clinical research solutions can support successful development programs across Europe and beyond.

The OCT DACH 2025 agenda will feature insightful sessions on:
🔹 Decentralized and Hybrid Trial Models – Leveraging innovation to enhance patient recruitment and retention.
🔹 Regulatory Updates – Navigating the evolving European clinical trial regulation landscape.
🔹 Operational Efficiency – Streamlining vendor management, data oversight, and risk mitigation.

With a strong presence across Europe and an expanding global footprint, Comac Medical continues to deliver comprehensive, end-to-end clinical trial services with a focus on quality, flexibility, and partnership.

Join us in Zurich, November 12–13, to connect with Diana Gheorghi and learn how Comac Medical can help accelerate your next clinical trial.
We look forward to meeting you at OCT DACH 2025!